Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations
  2. Abubakar, Mustapha; Zhang, Jing; Ahearn, Thomas U.; Koka, Hela; Guo, Changyuan; Lawrence,Scott; Mutreja,Karun; Figueroa, Jonine D.; Ying, Jianming; Lissowska, Jolanta; Lyu, Ning; Garcia-Closas, Montserrat; Yang, Xiaohong Rose
  3. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2021, Jul; 30(7): 1397-1407.
  1. 2.   Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk
  2. Abubakar, Mustapha; Fan, Shaoqi; Bowles, Erin Aiello; Widemann, Lea; Duggan, Maire A.; Pfeiffer, Ruth M.; Falk, Roni T.; Lawrence,Scott; Richert-Boe, Kathryn; Glass, Andrew G.; Kimes, Teresa M.; Figueroa, Jonine D.; Rohan, Thomas E.; Gierach, Gretchen L.
  3. JNCI cancer spectrum. 2021, Jun; 5(3):
  1. 3.   Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage
  2. Zhu, M.; Yi, M.; Kim, C. H.; Deng, C. X.; Li, Y.; Medina, D.; Stephens, R. M.; Green, J. E.
  3. Genome Biology. 2011, Aug 16; 12(8): 16.
  1. 4.   Why Does Binding of Proteins to DNA or Proteins to Proteins Not Necessarily Spell Function?
  2. Ma, B. Y.; Tsai, C. J.; Pan, Y. P.; Nussinov, R.
  3. Acs Chemical Biology. 2010, Mar; 5(3): 265-272.
  1. 5.   Cadmium Malignantly Transforms Normal Human Breast Epithelial Cells into a Basal-like Phenotype
  2. Benbrahim-Tallaa, L.; Tokar, E. J.; Diwan, B. A.; Dill, A. L.; Coppin, J. F.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2009 117(12): 1847-1852.
  1. 6.   Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
  2. Norris, J. D.; Joseph, J. D.; Sherk, A. B.; Juzumiene, D.; Turnbull, P. S.; Rafferty, S. W.; Cui, H. X.; Anderson, E.; Fan, D. J.; Dye, D. A.; Deng, X.; Kazmin, D.; Chang, C. Y.; Willson, T. M.; McDonnell, D. P.
  3. Chemistry & Biology. 2009 16(4): 452-460.
  1. 7.   Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide
  2. Varricchio, L.; Migliaccio, A.; Castoria, G.; Yamaguchi, H.; de Falco, A.; Di Domenico, M.; Giovannelli, P.; Farrar, W.; Appella, E.; Auricchio, F.
  3. Molecular Cancer Research. 2007, Nov; 5(11): 1213-1221.
  1. 8.   E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells
  2. Mani, A.; Oh, A. S.; Bowden, E. T.; Lahusen, T.; Lorick, K. L.; Weissman, A. M.; Schlegel, R.; Wellstein, A.; Riegel, A. T.
  3. Cancer Research. 2006, Sep; 66(17): 8680-8686.
  1. 9.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 10.   Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Belousov, P. V.; Kuz'mina, K. E.; Radko, B. V.; Longpre, F.; Lagarkova, M. A.; Kadachigova, T. S.; Gurova, O. V.; Meshcheryakov, A. A.; Lichinitser, M. R.; Knuth, A.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. International Journal of Cancer. 2005, DEC 10; 117(5): 800-806.
  1. 11.   An estrogen receptor chimera senses ligands by nuclear translocation
  2. Martinez, E. D.; Rayasam, G. V.; Dull, A. B.; Walker, D. A.; Hager, G. L.
  3. Journal of Steroid Biochemistry and Molecular Biology. 2005, DEC; 97(4): 307-321.
  1. 12.   A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
  2. Burger, A. M.; Gao, Y. G.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y. L.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K.
  3. Cancer Research. 2005, NOV 15; 65(22): 10401-10412.
  1. 13.   Nuclear receptors as negative modulators of STAT3 in multiple myeloma
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Cell Cycle. 2005, FEB; 4(2): 242-245.
  1. 14.   Estrogen receptor genotypes and haplotypes associated with breast cancer risk
  2. Gold, B.; Kalush, F.; Bergeron, J.; Scott, K.; Mitra, N.; Wilson, K.; Ellis, N.; Huang, H.; Chen, M.; Lippert, R.; Halldorsson, B. V.; Woodworth, B.; White, T.; Clark, A. G.; Parl, F. F.; Broder, S.; Dean, M.; Offit, K.
  3. Cancer Research. 2004, DEC 15; 64(24): 8891-8900.
  1. 15.   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models
  2. Fichtner, I.; Monks, A.; Hose, C.; Stevens, M. F. G.; Bradshaw, T. D.
  3. Breast Cancer Research and Treatment. 2004, SEP; 87(1): 97-107.
  1. 16.   Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Mihalic, K.; Fan, Y. X.; Xiao, W. H.; Howard, O. M. Z.; Appella, E.; Maynard, A. T.; Farrar, W. L.
  3. Nature Medicine. 2004 10(1): 40-47.
  1. 17.   Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero
  2. Waalkes, M. P.; Liu, J.; Chen, H.; Xie, Y. X.; Achanzar, W. E.; Zhou, Y. S.; Cheng, M. L.; Diwan, B. A.
  3. Journal of the National Cancer Institute. 2004 96(6): 466-474.
  1. 18.   Transcriptional inactivation of STAT3 by PPAR gamma suppresses IL-6-responsive multiple myeloma cells
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Huang, J. Q.; Hou, J.; Li, J.; Xiong, H.; Mihalic, K.; Zhu, H. M.; Xiao, W. H.; Farrar, W. L.
  3. Immunity. 2004 20(2): 205-218.
  1. 19.   Treatment with lovastatin, cholestyramine or niacin alters K- ras membrane association in mouse lung in a strain-dependent manner: results in females
  2. Calvert, R. J.; Tepper, S.; Diwan, B. A.; Anderson, L. M.; Kritchevsky, D.
  3. Biochemical Pharmacology. 2003 66(3): 393-403.
  1. 20.   Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4- amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
  2. Hose, C. D.; Hollingshead, M.; Sausville, E. A.; Monks, A.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1265-1272.
  1. 21.   Initiating oncogenic event determines gene-expression patterns of human breast cancer models
  2. Desai, K. V.; Xiao, N.; Wang, W.; Gangi, L.; Greene, J.; Powell, J. I.; Dickson, R.; Furth, P.; Hunter, K.; Kucherlapati, R.; Simon, R.; Liu, E. T.; Green, J. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(10): 6967-6972.
  1. 22.   A novel palladium-mediated coupling approach to 2,3- disubstituted benzo[b]thiophenes and its application to the synthesis of tubulin binding agents
  2. Flynn, B. L.; Verdier-Pinard, P.; Hamel, E.
  3. Organic Letters. 2001 3(5): 651-654.
  1. 23.   Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
  2. Sinai, C. J.; Tohkin, M.; Miyata, M.; Ward, J. M.; Lambert, G.; Gonzalez, F. J.
  3. Cell. 2000 102(6): 731-744.
  1. 24.   A new anti-tubulin agent containing the benzo
  2. Pinney, K. G.; Bounds, A. D.; Dingeman, K. M.; Mocharla, V. P.; Pettit, G. R.; Bai, R.; Hamel, E.
  3. Bioorganic & Medicinal Chemistry Letters. 1999 9(8): 1081-1086.
  1. 25.   Analysis of 2-(3-methyl-4-aminophenyl)-benzothiazole (NSC 674495) in plasma by gas chromatography with mass-selective detection
  2. Phillips, L. R.; Bramhall, C.; Buckley, J.; Daw, T. W.; Stinson, S. F.
  3. Journal of Chromatography B. 1999 732(2): 315-321.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel